PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $83,000 | -8.8% | 1,561 | 0.0% | 0.02% | -8.7% |
| Q2 2022 | $91,000 | -48.3% | 1,561 | -32.7% | 0.02% | -42.5% |
| Q1 2022 | $176,000 | +633.3% | 2,318 | +489.8% | 0.04% | +566.7% |
| Q4 2021 | $24,000 | +9.1% | 393 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $22,000 | -59.3% | 393 | -56.0% | 0.01% | -57.1% |
| Q2 2021 | $54,000 | -81.2% | 893 | -78.2% | 0.01% | -83.1% |
| Q1 2021 | $287,000 | +825.8% | 4,093 | +694.8% | 0.08% | +730.0% |
| Q4 2020 | $31,000 | -24.4% | 515 | -23.7% | 0.01% | +25.0% |
| Q3 2020 | $41,000 | -47.4% | 675 | -54.6% | 0.01% | -72.4% |
| Q2 2020 | $78,000 | +212.0% | 1,487 | +102.3% | 0.03% | +141.7% |
| Q1 2020 | $25,000 | -24.2% | 735 | 0.0% | 0.01% | -7.7% |
| Q4 2019 | $33,000 | +17.9% | 735 | 0.0% | 0.01% | +30.0% |
| Q3 2019 | $28,000 | +3.7% | 735 | +20.3% | 0.01% | -9.1% |
| Q2 2019 | $27,000 | +17.4% | 611 | 0.0% | 0.01% | +10.0% |
| Q1 2019 | $23,000 | – | 611 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |